Coya Therapeutics Reports Additional Proof-of-Concept Clinical Biomarker Data in Patients with Alzheimers Disease

COYA Stock   6.09  0.05  0.83%   
About 50% of Coya Therapeutics,'s investors are presently thinking to get in. The analysis of overall sentiment of trading Coya Therapeutics, Common stock suggests that some investors are interested at this time. The current market sentiment, together with Coya Therapeutics,'s historical and current headlines, can help investors time the market. In addition, many technical investors use Coya Therapeutics, Common stock news signals to limit their universe of possible portfolio assets.
  
Coya Therapeutics, Inc. , a clinical-stage biotechnology company developing multiple therapeutic platforms int

Read at businesswire.com
businesswire News
  

Coya Therapeutics, Fundamental Analysis

We analyze Coya Therapeutics,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Coya Therapeutics, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Coya Therapeutics, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Debt

Total Debt Comparative Analysis

Coya Therapeutics, is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.

Coya Therapeutics, Common Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Coya Therapeutics, stock to make a market-neutral strategy. Peer analysis of Coya Therapeutics, could also be used in its relative valuation, which is a method of valuing Coya Therapeutics, by comparing valuation metrics with similar companies.

Peers

Coya Therapeutics, Related Equities

CUECue Biopharma   1.94   
0%
13.0%
CNTACentessa Pharmaceuticals   1.92   
0%
13.0%
OPTOpthea   1.11   
0%
7.0%
ELYMEliem Therapeutics   0.31   
2.0%
0%
STROSutro Biopharma   2.11   
14.0%
0%
DAWNDay One   2.46   
16.0%
0%
CGTXCognition Therapeutics   2.56   
17.0%
0%
HLVXHillevax   2.60   
17.0%
0%
TFFPTff Pharmaceuticals   3.13   
21.0%
0%
DRMADermata Therapeutics   3.97   
27.0%
0%
TCRXTscan Therapeutics   5.39   
37.0%
0%
FENCFennec Pharmaceuticals   5.77   
39.0%
0%
ABOSAcumen Pharmaceuticals   6.19   
42.0%
0%
INABIn8bio   6.25   
43.0%
0%
GANXGain Therapeutics   7.07   
48.0%
0%
INZYInozyme Pharma   7.81   
53.0%
0%
LTRNLantern Pharma   8.62   
59.0%
0%
TERNTerns Pharmaceuticals   9.04   
62.0%
0%
NAMSWNewAmsterdam Pharma   14.53   
100.0%
0%

Complementary Tools for Coya Stock analysis

When running Coya Therapeutics,'s price analysis, check to measure Coya Therapeutics,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Coya Therapeutics, is operating at the current time. Most of Coya Therapeutics,'s value examination focuses on studying past and present price action to predict the probability of Coya Therapeutics,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Coya Therapeutics,'s price. Additionally, you may evaluate how the addition of Coya Therapeutics, to your portfolios can decrease your overall portfolio volatility.
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Stocks Directory
Find actively traded stocks across global markets
Equity Valuation
Check real value of public entities based on technical and fundamental data
Commodity Directory
Find actively traded commodities issued by global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance